Olasehinde Olalekan, Fagbayimu Michael Oluwatobiloba, Aderounmu Adewale, Komolafe Tolulope, Ameen Muftiat, Alatise Olusegun, Adisa Adewale
Department of Surgery, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria.
Department of Surgery, Obafemi Awolowo University, Ile-Ife, Nigeria.
Breast Care (Basel). 2024 Jun;19(3):135-141. doi: 10.1159/000536080. Epub 2024 Mar 3.
In Nigeria, mastectomy is the most common surgical treatment for breast cancer. Patients are often kept on admission for days until wound drains are removed. An early discharge programme was piloted in a Nigerian hospital in 2017 with very satisfactory outcomes. The impact of this evidence on clinical practice and surgical outcomes was evaluated over 5 years.
From a prospectively maintained institutional database, the details of patients who underwent mastectomy between 2018 and 2022 were obtained. The duration of post-operative stay was obtained and analysed per year to determine the trend. Post-operative surgical complications such as seroma, haematoma, flap necrosis, and surgical site infection were analysed.
Overall, 147 patients (69%) had early discharge during the review period. Twenty-two patients (10.3%) were discharged within 24 h of surgery, 61 patients (28.6%) were discharged within 24-48 h, and 64 patients (30%) were discharged between 48 and 72 h. There was a steady increase in the adoption of the early discharge protocol over time with a 50% adoption rate in 2018 and 95% in 2022. The mean duration of hospital stay declined steadily from 3.9 days in 2018 to 2.2 days in 2022. Early discharge did not result in any compromise to post-operative outcomes.
This study demonstrates the sustainability of early post-mastectomy discharge in a resource-limited setting with very satisfactory outcomes. It also provides a unique example of how locally generated evidence can guide local practice. We consider these findings generalisable in other Nigerian hospitals and low- and middle-income countries with similar contexts.
在尼日利亚,乳房切除术是乳腺癌最常见的外科治疗方法。患者通常需要住院数天,直到伤口引流管拔除。2017年,一家尼日利亚医院试行早期出院计划,取得了非常令人满意的结果。对这一证据对临床实践和手术结果的影响进行了为期5年的评估。
从一个前瞻性维护的机构数据库中,获取了2018年至2022年间接受乳房切除术患者的详细信息。每年获取并分析术后住院时间以确定趋势。分析术后手术并发症,如血清肿、血肿、皮瓣坏死和手术部位感染。
总体而言,在审查期间,147名患者(69%)实现了早期出院。22名患者(10.3%)在手术后24小时内出院,61名患者(28.6%)在24至48小时内出院,64名患者(30%)在48至72小时内出院。随着时间的推移,早期出院方案的采用率稳步上升,2018年为50%,2022年为95%。平均住院时间从2018年的3.9天稳步下降至2022年的2.2天。早期出院并未导致术后结果受到任何影响。
本研究表明,在资源有限的环境中,乳房切除术后早期出院具有可持续性,且结果非常令人满意。它还提供了一个独特的例子,说明本地产生的证据如何指导本地实践。我们认为这些发现可推广到其他尼日利亚医院以及具有类似情况的低收入和中等收入国家。